Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Alzheimer Disease ll: Pathophysiology

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Functional Defect Conferred by the Parkinson's Disease-Causing α-Synuclein (Ala30Pro) Mutation.

Methods in molecular medicine·2011

Same author

Determination of alpha-synuclein concentration in human plasma using ELISA.

Scandinavian journal of clinical and laboratory investigation·2007

Same author

Differential localization of alpha-, beta- and gamma-synucleins in the rat CNS.

Neuroscience·2002

Same author

Evidence for binding of human pregnancy zone protein-proteinase complex to alpha 2-macroglobulin receptors.

Biochimica et biophysica acta·1986

Search research articles

Related Experiment Video

Updated: Jun 4, 2026

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Published on: September 28, 2019

α-Synuclein/Amyloid Interactions.

P Henning Jensen¹

¹Department of Medical Biochemistry, University of Aarhus, Denmark.

Methods in Molecular Medicine

|February 15, 2011

Summary

This summary is machine-generated.

Human alpha-synuclein, a protein linked to Alzheimer's disease, may play a role in amyloid plaque formation. Studies explore its interaction with amyloid-beta peptides and senile plaques in the brain.

More Related Videos

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry for the Study of Alpha-Synuclein Structural Dynamics Under Physiological Conditions

Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry for the Study of Alpha-Synuclein Structural Dynamics Under Physiological Conditions

Published on: June 23, 2022

Related Experiment Videos

Last Updated: Jun 4, 2026

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Published on: September 28, 2019

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry for the Study of Alpha-Synuclein Structural Dynamics Under Physiological Conditions

Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry for the Study of Alpha-Synuclein Structural Dynamics Under Physiological Conditions

Published on: June 23, 2022

Area of Science:

Neuroscience
Biochemistry
Molecular Biology

Background:

Human alpha-synuclein is the precursor to the non-Aβ component (NAC) found in Alzheimer's disease amyloid plaques.
Amyloid plaques are primarily composed of amyloid-beta (Aβ) peptides, derived from the amyloid precursor protein (APP).
The mechanism of alpha-synuclein's integration into extracellular plaques remains unclear.

Purpose of the Study:

To investigate the interactions between alpha-synuclein and amyloid plaques.
To examine the role of alpha-synuclein and its NAC fragment in amyloid plaque biology.
To provide methodologies for studying these interactions in vitro and in situ.

Main Methods:

Expression and purification of recombinant human alpha-synuclein.
Sodium dodecyl sulfate (SDS) gel electrophoresis and fluorography.
Histologic techniques for human brain tissue fixation, sectioning, and handling.

Main Results:

In vitro studies demonstrate NAC and alpha-synuclein interact with Aβ peptides.
NAC and alpha-synuclein can form amyloid fibrils and stimulate Aβ aggregation.
Alpha-synuclein has been shown to stimulate Aβ aggregation and interact with plaques in situ.

Conclusions:

Alpha-synuclein and its NAC fragment possess the potential to actively participate in amyloid plaque formation.
The provided techniques facilitate the study of alpha-synuclein interactions with brain tissue and Aβ peptides.
Further research is warranted to elucidate the precise mechanisms involved in alpha-synuclein's role in Alzheimer's disease pathology.